Modification To: Tamper Evident Ultrasafe Passive Delivery System, Ultrasafe Passive Delivery System (X-Series)
510(k) K060743
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK060743 | Date28 Apr 2006 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- MEG
- Device Class
- Class II
- Regulation
- 21 CFR Part 880.5860
- Advisory Committee
- General Hospital
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 24 Sep 2026
This device is a syringe, antistick, classified as a Class II medical device under FDA regulation 880.5860. It is a modification to the tamper-evident Ultrasafe passive delivery system, designed as an accessory for use with prefilled ISO standard glass syringes to aid in the protection of healthcare professionals.
The device is supplied as a single-use accessory and is indicated for use in general hospital settings. It received FDA 510(k) clearance (K060743) on April 28, 2006, as substantially equivalent to a predicate device. The product code is MEG, and it is manufactured by Safety Syringes, Inc. in Carlsbad, California.
Other devices from Safety Syringes, Inc.
Questions
AI-generated answers, 24 Sep 2026
What is the Modification to Tamper Evident Ultrasafe Passive Delivery System X-Series used for?
It is an accessory designed to aid in the protection of healthcare professionals when used with prefilled ISO standard glass syringes in general hospital settings, as indicated in the device description.
Is the Modification to Tamper Evident Ultrasafe Passive Delivery System X-Series supplied sterile and for single-use only?
The device is supplied as a single-use accessory, meaning it is intended for one-time use and should not be reused, based on its classification and intended use as an accessory for prefilled syringes.
What regulatory pathway was used for the Modification to Tamper Evident Ultrasafe Passive Delivery System X-Series?
The device received FDA 510(k) clearance (K060743) on April 28, 2006, as substantially equivalent to a predicate device, which is the regulatory pathway indicated in the authorizations and decision description.